2015 - 2018 Towards personalized treatment of diffuse gliomas based on molecular characteristics
2012 - 2015 A novel chemotherapy of malignant glioma by concomitant use of inhibitors for angiogenetic factor and hypoxia-inducible factor
2011 - 2013 Towards molecular classification and individualized treatment of glioma
2008 - 2010 Chemosensitization of human glioma cellt to chemotherapeutic agent temozolomide
2008 - 2010 Towards molecular classification and individualized treatment of gliomas
2004 - 2006 Investigation on Akt kinase as a chemoresistance-promoting factor in human glioma cells
1993 - 1993 培養ヒト神経芽細胞腫におけるアミロイド前駆体蛋白mRNAの発現様式の変化
Show all
Papers (422):
Masayuki Kanamori, Ichiyo Shibahara, Yoshiteru Shimoda, Yukinori Akiyama, Takaaki Beppu, Shigeo Ohba, Toshiyuki Enomoto, Takahiro Ono, Yuta Mitobe, Mitsuto Hanihara, et al. Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection. International journal of clinical oncology. 2024
Jun Muto, Hirofumi Nakatomi, Yuichi Hirose. Cadaveric Feasibility of Robotic-Assisted Radial Artery-Internal Carotid Artery-Middle Cerebral Artery Anastomosis for Neurovascular Surgery. Operative neurosurgery (Hagerstown, Md.). 2024
Miyuki Hirosue, Mai Okubo, Tomoka Katayama, Riki Tanaka, Kento Sasaki, Yoko Kato, Yuichi Hirose, Ahmed Ansari. Nurse Practitioners: An Untapped Resource on the Overburdened Health System. Asian journal of neurosurgery. 2024. 19. 3. 576-577
Kiyonori Kuwahara, Ichiro Nakahara, Shoji Matsumoto, Yoshio Suyama, Jun Morioka, Akiko Hasebe, Jun Tanabe, Sadayoshi Watanabe, Kenichiro Suyama, Yuichi Hirose. Mechanical thrombectomy for occlusion of the fenestrated middle cerebral artery M1 segment: A case report and review of the literature. Radiology case reports. 2024. 19. 5. 1692-1696
Hikaru Sasaki, Yohei Kitamura, Masahiro Toda, Yuichi Hirose, Kazunari Yoshida. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy. Brain tumor pathology. 2024. 41. 2. 43-49